Top 10 Takeover Targets of 2026
The year has gotten off to a warm start, though not quite red hot, when it comes to biopharma merger-and-acquisition (M&A) deals. Market watchers rang in 2026 expecting the value and number of biopharma M&A deals to accelerate. Indeed Merck & …